- In October 2024, the Bristol-based health tech start-up Siloton secured USD 1,066,400 to further develop its Akepa OCT chip technology, which targets age-related macular degeneration (AMD), the leading cause of sight loss in the U.K. This funding will help support the commercial rollout, with plans to capture the first chip-based OCT image by the end of the year and release a research version in 2025
- In May 2024, Palleos Healthcare GmbH, an oncology-focused CRO, and OCT Global SA, under OCT Clinical, merged to create a stronger presence in clinical research. The merger, backed by Swiss XlifeSciences AG, represents a significant milestone, fostering collaboration and growth in the clinical research sector
- In February 2024, the Advanced Research Projects Agency for Health (ARPA-H) announced a USD 20 million initiative to develop a compact and affordable optical coherence tomography (OCT) device. This initiative is aimed at improving early detection and intervention for eye diseases, potentially preventing severe visual impairments
- In April 2022, Alcon expanded its training and education offerings with the launch of the Alcon Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator. This portable VR tool is designed to aid cataract surgeons in training, enhancing their skills in a virtual environment
- In January 2022, Haag-Streit UK (HS-UK) introduced the Optovue iScan80, a high-speed OCT system. Ideal for practices seeking an affordable and versatile solution, the device features a compact design that integrates the operator interface, display, patient interface, and scan head into a single console, making it perfect for small spaces
